Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION (CVS)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

CVS Health : to Keep Aetna Headquarters in Hartford, Conn.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/12/2018 | 09:50pm CEST
By Joseph De Avila 

CVS Health Corp. has decided to keep Aetna Inc. in Hartford, Conn., reversing the insurer's plan announced last year to move its corporate headquarters to New York City.

"We have no plans to relocate Aetna's operations from Hartford," CVS spokesman David Palombi said, adding that the company had met with Connecticut Gov. Dannel Malloy and Hartford Mayor Luke Bronin on Thursday.

The planned move was put on hold after CVS's December announcement that it would buy Aetna for $69 billion. Aetna said at the time the merger was announced that all of its locations would be evaluated as part of its integration with CVS.

CVS will maintain its corporate headquarters in Rhode Island.

The reversal is a win for Connecticut, which has lost other corporate residents in recent years and has been struggling with budget shortfalls and declining population. The city of Hartford is in its own financial straits, relying on state aid to balance its budget.

"I'm thrilled that CVS has confirmed that Aetna will continue to call Hartford home," Mr. Malloy said.

At the time that Aetna announced its decision to leave Hartford, where it has been based since 1853, the insurer said it chose to move to New York to tap a more robust pool of talent as it sought to reposition itself as a consumer-oriented health company.

Earlier this week, New York City said it was shelving a $9.6 million incentive package offered to Aetna. The insurer had planned to move into a 170,000-square-foot Chelsea building developed by Vornado Realty Trust and Aurora Capital Associates.

Write to Joseph De Avila at [email protected]

Stocks mentioned in the article
ChangeLast1st jan.
AETNA -0.11% 191.33 Delayed Quote.6.18%
CVS HEALTH CORPORATION -0.06% 67.9 Delayed Quote.-6.29%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORPORATION
06:06pCVS HEALTH : Schofield added to CVS' transition program
AQ
02:01pCVS HEALTH : Expands Commitment to Veterans Transitioning to Civilian Life
PR
12:51pCVS HEALTH : AG Steve Marshall, CVS Health Announce Safe Drug Disposal Program i..
AQ
12:31pCVS HEALTH : Raimondo Bringing New Job Training Center to Woonsocket
AQ
07/17CVS HEALTH : Foundation awards $60,000 in grants
AQ
07/17CVS HEALTH : Empirical Financial Services Cut Its Apple (AAPL) Stake by $6.26 Mi..
AQ
07/16CVS HEALTH : 2 CVS workers lose jobs after cops called on black customer
AQ
07/16CVS HEALTH : Responds to Request for Information on Trump Administration's Bluep..
PR
07/16CORRECTION : CVS-Black Customer story
AQ
07/16CVS HEALTH : 2 CVS workers fired after coupon incident at Edgewater store
AQ
More news
News from SeekingAlpha
03:08pFDA committed to easing approval path for biosimilars 
08:32a10 Dividend Growth Stocks For July 2018 
07/1712 DIVIDEND INCREASES : July 2-13, 2018 
07/17Buying Dividend Growth Stocks Without Looking - More Than 3 Years Later. 
07/16DIVIDEND SENSEI'S PORTFOLIO UPDATE 4 : The 3 Essential Things All Investors Need.. 
Financials ($)
Sales 2018 189 B
EBIT 2018 10 003 M
Net income 2018 5 433 M
Debt 2018 19 470 M
Yield 2018 3,10%
P/E ratio 2018 13,12
P/E ratio 2019 10,34
EV / Sales 2018 0,47x
EV / Sales 2019 0,43x
Capitalization 69 071 M
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 85,4 $
Spread / Average Target 26%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH CORPORATION-6.29%69 071
WALGREENS BOOTS ALLIANCE-10.27%65 132
EXPRESS SCRIPTS HOLDING CO7.02%44 870
MCKESSON CORPORATION-13.70%27 155
AMERISOURCEBERGEN-5.45%19 083
CARDINAL HEALTH-17.24%15 525